Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Insulin Signaling WP481	12/160	7.108085378581634E-4	0.33550162986905313	0	0	2.9999999999999996	21.74732235041337	LIPE;SHC2;PRKCH;RPS6KA2;IRS4;TSC1;PIK3R2;FOXO3;SOS2;MAP3K11;VAMP2;MAP3K12
Angiopoietin Like Protein 8 Regulatory Pathway WP3915	10/132	0.0017942272043924912	0.42343762023662795	0	0	3.0303030303030303	19.161154171351537	SHC2;RXRA;RPS6KA2;IRS4;TSC1;PIK3R2;FOXO3;SOS2;MAP3K11;MAP3K12
Phosphodiesterases in neuronal function WP4222	6/53	0.002010576111795613	0.31633064158917645	0	0	4.528301886792453	28.1177387556033	ADCY9;PDE6G;PDE9A;ADCY6;ADCY5;GRIN2D
Statin Pathway WP430	4/29	0.005583621105065782	0.6588672903977623	0	0	5.517241379310344	28.622994590353443	ABCA1;APOC1;PLTP;FDFT1
Thermogenesis WP4321	8/108	0.0057383380562570354	0.5416991125106642	0	0	2.962962962962963	15.290624141665512	LIPE;ADCY9;RPS6KA2;TSC1;SMARCA2;SOS2;ADCY6;ADCY5
Imatinib and Chronic Myeloid Leukemia WP3640	3/20	0.012902143644594305	1.0	0	0	5.999999999999999	26.10217084452193	CDKN1B;KIT;FOXO3
Neural Crest Differentiation WP2064	7/101	0.013413164283940805	0.9044305060028657	0	0	2.7722772277227725	11.952724956502475	CDH1;HDAC11;DVL3;PAX3;ETS1;HDAC6;HES5
NAD Biosynthesis II (from tryptophan) WP2485	2/8	0.01580491452517871	0.9324899569855438	0	0	10.0	41.47434341416576	HAAO;NADSYN1
Notch Signaling Pathway WP61	5/61	0.01808225984730525	0.9483140719920087	0	0	3.2786885245901636	13.156799804178378	HES6;TLE1;APH1B;PIK3R2;HES5
Benzo(a)pyrene metabolism WP696	2/9	0.019987498286726836	0.9434099191335067	0	0	8.888888888888888	34.779095880349324	EPHX1;CYP1B1
Pathways Affected in Adenoid Cystic Carcinoma WP3651	5/65	0.023168811652081647	0.994152645434776	0	0	3.076923076923077	11.584456092514266	BRD1;NSD1;MGA;FOXO3;SMARCA2
Type III interferon signaling WP2113	2/10	0.02457569018526242	0.9666438139536552	0	0	8.0	29.64798022792225	STAT2;IRF9
Nuclear Receptors Meta-Pathway WP2882	14/319	0.030479017622172415	1.0	0	0	1.7554858934169277	6.127904063319746	CDKN1B;TSC22D3;GSTP1;SLC39A13;SERPINB9;SLC5A10;CES4A;SLC6A6;RXRA;FTH1;CYP1B1;AHRR;PLTP;IP6K3
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844	3/30	0.038268755933891604	1.0	0	0	4.0	13.052485950718438	CDKN1B;PIK3R2;FOXO3
Serotonin and anxiety-related events WP3944	2/13	0.040550197611673826	1.0	0	0	6.153846153846154	19.724397693220933	PLCD4;GRIN2D
Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813	2/15	0.05283270093282616	1.0	0	0	5.333333333333333	15.683333035361262	ZEB2;CDH1
Chemokine signaling pathway WP3929	8/164	0.05421455955607076	1.0	0	0	1.951219512195122	5.687425912418347	SHC2;ADCY9;STAT2;PIK3R2;FOXO3;SOS2;ADCY6;ADCY5
Signaling Pathways in Glioblastoma WP2261	5/82	0.05456121322238969	1.0	0	0	2.4390243902439024	7.093736656618068	CDKN1B;PRKCH;TSC1;PIK3R2;FOXO3
Ectoderm Differentiation WP2858	7/138	0.058456240913430456	1.0	0	0	2.028985507246377	5.761257322482767	RIT1;PAX3;LDB2;NLK;CELSR2;HDAC6;SERPINB6
Tryptophan catabolism leading to NAD+ production WP4210	2/16	0.05940541077305161	1.0	0	0	5.0	14.116849831533036	HAAO;NADSYN1
Kit receptor signaling pathway WP304	4/59	0.059897577419752636	1.0	0	0	2.711864406779661	7.634221609280811	KIT;PIK3R2;FOXO3;SOCS6
Target Of Rapamycin (TOR) Signaling WP1471	3/36	0.06037988610364689	1.0	0	0	3.333333333333333	9.356997470103483	DDIT4L;ULK2;TSC1
Type II interferon signaling (IFNG) WP619	3/37	0.06453588403923348	1.0	0	0	3.2432432432432434	8.888217950878486	STAT2;IRF9;IFIT2
Serotonin and anxiety WP3947	2/17	0.0662415915707929	1.0	0	0	4.705882352941176	12.773867020503221	POMC;PLCD4
Endometrial cancer WP4155	4/63	0.07265625462332848	1.0	0	0	2.5396825396825395	6.659087746355557	CDH1;PIK3R2;FOXO3;SOS2
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879	2/18	0.07332402120449992	1.0	0	0	4.444444444444444	11.612742279715478	TSC1;MAP3K11
NRF2 pathway WP2884	7/146	0.07419886464024615	1.0	0	0	1.917808219178082	4.988231510107349	SLC6A6;RXRA;FTH1;GSTP1;SLC39A13;SLC5A10;CES4A
Farnesoid X Receptor  Pathway WP2879	2/19	0.08063617099611983	1.0	0	0	4.2105263157894735	10.601296667256518	RXRA;IP6K3
Non-small cell lung cancer WP4255	4/66	0.08305732510112497	1.0	0	0	2.4242424242424243	6.03205877749113	RXRA;PIK3R2;FOXO3;SOS2
Breast cancer pathway WP4262	7/154	0.0922082266047438	1.0	0	0	1.8181818181818181	4.33401077591269	HEYL;SHC2;KIT;DVL3;PIK3R2;SOS2;HES5
Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341	4/71	0.10190606046315834	1.0	0	0	2.2535211267605635	5.14637490908864	PRKCH;RXRA;STAT2;ETS1
Notch Signaling WP268	3/45	0.10215828081331627	1.0	0	0	2.6666666666666665	6.0832850553957645	APH1B;DVL3;HES5
NAD+ biosynthetic pathways WP3645	2/22	0.10379556080326813	1.0	0	0	3.6363636363636362	8.237571185428129	NADSYN1;SIRT2
PI3K/AKT/mTOR - VitD3 Signalling WP4141	2/22	0.10379556080326813	1.0	0	0	3.6363636363636362	8.237571185428129	RXRA;TSC1
Aryl Hydrocarbon Receptor Pathway WP2873	3/46	0.10736313441562158	1.0	0	0	2.6086956521739126	5.821404549935052	CDKN1B;CYP1B1;AHRR
Aryl Hydrocarbon Receptor WP2586	3/46	0.10736313441562158	1.0	0	0	2.6086956521739126	5.821404549935052	CDKN1B;CYP1B1;AHRR
Nanoparticle triggered autophagic cell death WP2509	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	ULK2;TSC1
The human immune response to tuberculosis WP4197	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	STAT2;IRF9
Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	FMO5
Sulindac Metabolic Pathway WP2542	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	CYP1B1
IL1 and megakaryocytes in obesity WP2865	2/24	0.12010982001247623	1.0	0	0	3.333333333333333	7.064495959797489	SELENBP1;TIMP2
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612	2/24	0.12010982001247623	1.0	0	0	3.333333333333333	7.064495959797489	GSTP1;EPHX1
Differentiation of white and brown adipocyte    WP2895	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	HSPB7;ZNF423
IL-7 Signaling Pathway WP205	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	CDKN1B;PIK3R2
MTHFR deficiency WP4288	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	HNMT;GRIN2D
Synaptic signaling pathways associated with autism spectrum disorder WP4539	3/50	0.12916025190606503	1.0	0	0	2.4	4.912083318606716	TSC1;PIK3R2;GRIN2D
PPAR Alpha Pathway WP2878	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	RXRA;PLTP
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932	11/303	0.13992019282470833	1.0	0	0	1.4521452145214522	2.855909408821777	LIPE;CDKN1B;PIK3IP1;CAB39L;LAMB2;KIT;VEGFB;IRS4;PIK3R2;TSC1;FOXO3
Wnt Signaling Pathway WP363	3/52	0.14059914501552925	1.0	0	0	2.3076923076923075	4.527328570603137	DVL3;TSC1;NLK
Benzene metabolism WP3891	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	EPHX1
DNA Damage Response (only ATM dependent) WP710	5/110	0.14165333955886242	1.0	0	0	1.8181818181818181	3.553404503369429	CDKN1B;DVL3;PIK3R2;FOXO3;SOS2
Sphingolipid pathway WP1422	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	CERS4;COL4A3BP
Interferon type I signaling pathways WP585	3/54	0.15236274042928305	1.0	0	0	2.222222222222222	4.1810914466514895	STAT2;PIK3R2;IRF9
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway WP2380	6/144	0.15271071655158933	1.0	0	0	1.6666666666666665	3.1320164813175846	SHC2;KSR1;PIK3R2;FOXO3;GRIA3;NFATC4
Aflatoxin B1 metabolism WP699	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	EPHX1
Arachidonate Epoxygenase / Epoxide Hydrolase WP678	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	GSTP1
Hypothetical Craniofacial Development Pathway WP3655	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	IRF6
MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	VEGFB
Calcium Regulation in the Cardiac Cell WP536	6/149	0.17044793665898042	1.0	0	0	1.610738255033557	2.8499200843945487	PRKCH;ADCY9;KCNB1;CACNA1A;ADCY6;ADCY5
Metapathway biotransformation Phase I and II WP702	7/183	0.17540955631823524	1.0	0	0	1.530054644808743	2.6632616443051336	CHST9;CYP2U1;GSTP1;EPHX1;CYP1B1;HNMT;FMO5
Integrated Breast Cancer Pathway WP1984	6/151	0.1777736824734573	1.0	0	0	1.5894039735099337	2.7452884520942322	GRN;RASGEF1A;CDH1;MYCBP2;TSC1;PIK3R2
Ras Signaling WP4223	7/184	0.17873041141519813	1.0	0	0	1.5217391304347827	2.6202471368065696	RAB5B;SHC2;KSR1;KIT;PIK3R2;ETS1;SOS2
MET in type 1 papillary renal cell carcinoma WP4205	3/59	0.18301812654553012	1.0	0	0	2.0338983050847457	3.453905245189201	PIK3R2;ETS1;SOS2
Apoptosis Modulation and Signaling WP1772	4/91	0.193365469000841	1.0	0	0	1.7582417582417582	2.889095839916935	HRK;MADD;BMF;TNFRSF10D
ErbB Signaling Pathway WP673	4/91	0.193365469000841	1.0	0	0	1.7582417582417582	2.889095839916935	SHC2;CDKN1B;PIK3R2;SOS2
TYROBP Causal Network WP3945	3/61	0.19571013951815233	1.0	0	0	1.9672131147540983	3.2087618250165857	CD4;KCNE3;NPC2
Alpha 6 Beta 4 signaling pathway WP244	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	LAMB2;PIK3R2
Prion disease pathway WP3995	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	RXRA;BATF
G Protein Signaling Pathways WP35	4/93	0.2036425912242253	1.0	0	0	1.7204301075268817	2.737873248162342	PRKCH;ADCY9;ADCY6;ADCY5
Degradation pathway of sphingolipids, including diseases WP4153	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	NEU3
Folate-Alcohol and Cancer Pathway Hypotheses WP1589	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	CBS
Heme Biosynthesis WP561	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	ALAD
Methylation Pathways WP704	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	HNMT
Epithelial to mesenchymal transition in colorectal cancer WP4239	6/159	0.20828095366766022	1.0	0	0	1.5094339622641508	2.368101693465638	ZEB2;CDH1;CLDN7;PKP1;PIK3R2;SOS2
Ebola Virus Pathway on Host WP4217	5/129	0.2216043819346316	1.0	0	0	1.5503875968992247	2.336219457722892	NPC2;PIK3R2;HLA-G;EPS15;TPCN2
Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases WP4518	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	OPLAH
Liver X Receptor Pathway WP2874	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	RXRA
Mammary gland development pathway - Involution (Stage 4 of 4) WP2815	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	CDH1
Trans-sulfuration pathway WP2333	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	CBS
Vitamin D Metabolism WP1531	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	RXRA
Human Thyroid Stimulating Hormone (TSH) signaling pathway WP2032	3/66	0.22829261173331122	1.0	0	0	1.8181818181818181	2.685685614666917	CDKN1B;KCNIP3;PIK3R2
PPAR signaling pathway WP3942	3/67	0.23493078009641188	1.0	0	0	1.7910447761194028	2.594264527179215	RXRA;ACOX3;PLTP
VEGFA-VEGFR2 Signaling Pathway WP3888	8/236	0.2395534890653661	1.0	0	0	1.3559322033898304	1.9375980348165265	SHC2;CTNND1;PIK3R2;FOXO3;SMARCA2;EPS15;ETS1;TPCN2
Methionine metabolism leading to Sulphur Amino Acids and related disorders WP4292	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	CBS
NAD metabolism, sirtuins and aging WP3630	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	FOXO3
AMP-activated Protein Kinase (AMPK) Signaling WP1403	3/69	0.24830518328238543	1.0	0	0	1.7391304347826086	2.4227768897492368	LIPE;TSC1;PIK3R2
Wnt Signaling Pathway and Pluripotency WP399	4/102	0.25164686509502815	1.0	0	0	1.5686274509803921	2.164280005079847	PRKCH;CTNND1;DVL3;NLK
IL-10 Anti-inflammatory Signaling Pathway  WP4495	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	STAT2
Iron metabolism in placenta WP2007	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	FTH1
Nanoparticle triggered regulated necrosis WP2513	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	RIPK3
Bladder Cancer WP2828	2/40	0.2642113633345378	1.0	0	0	2.0	2.662011754937148	CDH1;PIK3R2
IL-5 Signaling Pathway WP127	2/40	0.2642113633345378	1.0	0	0	2.0	2.662011754937148	PIK3R2;FOXO3
Primary Focal Segmental Glomerulosclerosis FSGS WP2572	3/72	0.2685696227705788	1.0	0	0	1.6666666666666665	2.1910751599377134	CDKN1B;LAMB2;IRF6
Endoderm Differentiation WP2853	5/141	0.2777848392359753	1.0	0	0	1.4184397163120568	1.816891382320096	EOMES;DAB2;PAX3;NLK;BPTF
Estrogen Receptor Pathway WP2881	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	CYP1B1
Ganglio Sphingolipid Metabolism WP1423	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	B3GALT4
IL-6 signaling pathway WP364	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	PIK3R2;NLK
Vitamin A and Carotenoid Metabolism WP716	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	RXRA;RETSAT
Cysteine and methionine catabolism WP4504	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	CBS
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	CDH1
Heart Development WP1591	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	VEGFB;NFATC4
Interleukin-11 Signaling Pathway WP2332	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	FES;PIK3R2
Vitamin D Receptor Pathway WP2877	6/182	0.304259249085134	1.0	0	0	1.3186813186813187	1.569066129170239	CDKN1B;RXRA;CBS;SALL4;TIMP2;TRAK1
Cholesterol Biosynthesis Pathway WP197	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	FDFT1
miRNAs involved in DNA damage response WP1545	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	CDKN1B
Tryptophan metabolism WP465	2/46	0.3199619156443703	1.0	0	0	1.7391304347826086	1.981831832838938	HAAO;CYP1B1
Energy Metabolism WP1541	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	RXRA;FOXO3
Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	MADD
Interactome of polycomb repressive complex 2 (PRC2)  WP2916	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	STK38
Metabolic pathway of LDL, HDL and TG, including diseases WP4522	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	ABCA1
NAD+ metabolism WP3644	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	SIRT2
SREBF and miR33 in cholesterol and lipid homeostasis WP2011	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	ABCA1
Exercise-induced Circadian Regulation WP410	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	PPP1R3C;GSTP1
Rett syndrome causing genes WP4312	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	HTT;SMARCA2
IL-9 Signaling Pathway WP22	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	PIK3R2
Leptin Insulin Overlap WP3935	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	IRS4
Vitamin B12 Metabolism WP1533	2/50	0.3565901556321914	1.0	0	0	1.5999999999999999	1.6498690882006875	ABCA1;CBS
Pathways in clear cell renal cell carcinoma WP4018	3/85	0.3575874776802259	1.0	0	0	1.4117647058823528	1.4518238879557512	KSR1;PGBD5;TSC1
Synaptic Vesicle Pathway WP2267	2/51	0.36564128501908433	1.0	0	0	1.5686274509803921	1.578200034140809	CACNA1A;VAMP2
Estrogen metabolism WP697	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	CYP1B1
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	RAB5B
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	CDH1
Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864	2/53	0.38359202335177106	1.0	0	0	1.5094339622641508	1.4463029892393837	CDKN1B;ETS1
IL-4 Signaling Pathway WP395	2/54	0.3924854550749619	1.0	0	0	1.4814814814814814	1.385564147526165	FES;PIK3R2
TGF-beta Receptor Signaling WP560	2/54	0.3924854550749619	1.0	0	0	1.4814814814814814	1.385564147526165	ZEB2;ZNF423
Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	FOXO3
Amino Acid metabolism WP3925	3/91	0.39839258143942596	1.0	0	0	1.3186813186813187	1.2136053287868656	AUH;CBS;HNMT
IL-1 signaling pathway WP195	2/55	0.40132045183103177	1.0	0	0	1.4545454545454544	1.3279927840918175	IRAK3;PIK3R2
TNF alpha Signaling Pathway WP231	3/92	0.40513108190704056	1.0	0	0	1.3043478260869563	1.1785364415810688	KSR1;RIPK3;MADD
Adipogenesis WP236	4/130	0.4094511420274484	1.0	0	0	1.2307692307692308	1.0990002388867115	LIPE;RXRA;STAT2;IRS4
Neovascularisation processes WP4331	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	KIT
Tamoxifen metabolism WP691	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	CYP1B1
TGF-beta Signaling Pathway WP366	4/132	0.42069740654476995	1.0	0	0	1.2121212121212122	1.0495047915438824	DAB2;ZEB2;PIK3R2;ETS1
Globo Sphingolipid Metabolism WP1424	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	GBGT1
Transcription factor regulation in adipogenesis WP3599	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	RXRA
Type II diabetes mellitus WP1584	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	CACNA1A
Vitamin D in inflammatory diseases WP4482	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	RXRA
miRNA targets in ECM and membrane receptors WP2911	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	LAMB2
B Cell Receptor Signaling Pathway WP23	3/97	0.4384603644337263	1.0	0	0	1.2371134020618557	1.0199825075033913	CD79B;PIK3R2;ETS1
Glutathione metabolism WP100	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	OPLAH
Pathways Regulating Hippo Signaling WP4540	3/98	0.4450435426086273	1.0	0	0	1.2244897959183672	0.9913263098498469	PRKCH;CDH1;KIT
Oxidation by Cytochrome P450 WP43	2/61	0.4529669891745948	1.0	0	0	1.3114754098360655	1.0386046265359035	CYP2U1;CYP1B1
Prader-Willi and Angelman Syndrome WP3998	2/61	0.4529669891745948	1.0	0	0	1.3114754098360655	1.0386046265359035	POMC;FEZ1
Angiogenesis WP1539	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	TIMP2
Triacylglyceride Synthesis WP325	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	LIPE
Proteasome Degradation WP183	2/62	0.46132803795917154	1.0	0	0	1.2903225806451613	0.9982527870331739	UBA7;HLA-G
Glycosylation and related congenital defects. WP4521	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	ALG9
Physiological and Pathological Hypertrophy  of the Heart WP1528	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	NFATC4
Lung fibrosis WP3624	2/63	0.46961389196045544	1.0	0	0	1.2698412698412698	0.9598024487193709	CYSLTR2;FAM13A
Cytokines and Inflammatory Response WP530	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	CD4
EPO Receptor Signaling WP581	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	PTPRU
Wnt/beta-catenin Signaling Pathway in Leukemia WP3658	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	SALL4
Oncostatin M Signaling Pathway WP2374	2/65	0.48595425402499	1.0	0	0	1.2307692307692308	0.8881732763477085	CDKN1B;PRKCH
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	CDKN1B;NEFH
Folate Metabolism WP176	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	ABCA1;CBS
Canonical  and Non-canonical Notch signaling WP3845	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	MFAP2
Eicosanoid Synthesis WP167	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	PTGDS
TLR4 Signaling and Tolerance WP3851	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	IRAK3
Lipid Metabolism Pathway WP3965	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	LIPE
MAPK Cascade WP422	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	MAP3K12
Selective expression of chemokine receptors during T-cell polarization WP4494	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	CD4
miRs in Muscle Cell Differentiation WP2012	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	PRKCH
Inflammatory Response Pathway WP453	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	LAMB2
Matrix Metalloproteinases WP129	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	TIMP2
Ethanol effects on histone modifications WP3996	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	HDAC6
Trans-sulfuration and one carbon metabolism WP2525	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	CBS
Nonalcoholic fatty liver disease WP4396	4/155	0.5446402358822579	1.0	0	0	1.032258064516129	0.6272307818732501	RXRA;PIK3R2;COX7A1;MAP3K11
Myometrial Relaxation and Contraction Pathways WP289	4/156	0.5497287550278442	1.0	0	0	1.0256410256410255	0.6136720975199073	PRKCH;ADCY9;ADCY6;ADCY5
Wnt Signaling WP428	3/115	0.5513922772104151	1.0	0	0	1.0434782608695652	0.6211917769826543	DVL3;NLK;NFATC4
Focal Adhesion WP306	5/198	0.553648211958356	1.0	0	0	1.01010101010101	0.5971977680763215	SHC2;LAMB2;VEGFB;PIK3R2;PPP1R12C
Constitutive Androstane Receptor Pathway WP2875	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	RXRA
Development and heterogeneity of the ILC family WP3893	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	EOMES
Initiation of transcription and translation elongation at the HIV-1 LTR WP3414	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	NFATC4
Ovarian Infertility Genes WP34	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	CDKN1B
White fat cell differentiation WP4149	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	ZNF423
Nuclear Receptors in Lipid Metabolism and Toxicity WP299	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	ABCA1
Pregnane X Receptor pathway WP2876	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	RXRA
Resistin as a regulator of inflammation WP4481	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	PLCD4
Signal transduction through IL1R WP4496	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	IRAK3
miRNA regulation of prostate cancer signaling pathways WP3981	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	CDKN1B
Spinal Cord Injury WP2431	3/118	0.5688860293435293	1.0	0	0	1.0169491525423728	0.5736357608562849	BCAN;CDKN1B;FOXO3
Prolactin Signaling Pathway WP2037	2/76	0.5699678510175187	1.0	0	0	1.0526315789473684	0.5917634962819259	RPS6KA2;PIK3R2
BDNF-TrkB Signaling WP3676	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	TSC1
Fatty Acid Beta Oxidation WP143	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	LIPE
EGF/EGFR Signaling Pathway WP437	4/162	0.5796164189136505	1.0	0	0	0.9876543209876543	0.5386555465960212	RPS6KA2;PIK3R2;SOS2;EPS15
MAPK Signaling Pathway WP382	6/246	0.5814853778414788	1.0	0	0	0.975609756097561	0.5289458077327067	DUSP3;CACNA1A;NLK;SOS2;MAP3K11;MAP3K12
Wnt Signaling in Kidney Disease WP4150	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	DVL3
Zinc homeostasis WP3529	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	SLC39A13
Melatonin metabolism and effects WP3298	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	CYP1B1
Amyotrophic lateral sclerosis (ALS) WP2447	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	NEFH
Nuclear Receptors WP170	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	RXRA
Parkinsons Disease Pathway WP2371	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	UBA7
Sleep regulation WP3591	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	PTGDS
PI3K-Akt Signaling Pathway WP4172	8/340	0.6185211074697218	1.0	0	0	0.9411764705882353	0.4521637278690725	CDKN1B;LAMB2;KIT;VEGFB;PIK3R2;TSC1;FOXO3;SOS2
Apoptosis WP254	2/84	0.6245526523539249	1.0	0	0	0.9523809523809523	0.44830442071927945	HRK;IRF6
MicroRNAs in cardiomyocyte hypertrophy WP1544	2/84	0.6245526523539249	1.0	0	0	0.9523809523809523	0.44830442071927945	PIK3R2;NFATC4
G13 Signaling Pathway WP524	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	PIK3R2
Ferroptosis WP4313	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	FTH1
Microglia Pathogen Phagocytosis Pathway WP3937	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	PIK3R2
Oxidative Damage WP3941	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	CDKN1B
Selenium Micronutrient Network WP15	2/86	0.6373322377682995	1.0	0	0	0.9302325581395349	0.4190364586262058	ABCA1;CBS
ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336	2/86	0.6373322377682995	1.0	0	0	0.9302325581395349	0.4190364586262058	DVL3;NLK
Retinoblastoma Gene in Cancer WP2446	2/87	0.6435930169797581	1.0	0	0	0.9195402298850575	0.40523100125149	CDKN1B;SMARCA2
Common Pathways Underlying Drug Addiction WP2636	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	GRIA3
IL-2 Signaling Pathway WP49	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	FOXO3
Androgen receptor signaling pathway WP138	2/90	0.6618632480006403	1.0	0	0	0.8888888888888888	0.3668411719125685	PIK3R2;BMF
T-Cell antigen Receptor (TCR)  Signaling Pathway WP69	2/90	0.6618632480006403	1.0	0	0	0.8888888888888888	0.3668411719125685	CD4;PIK3R2
Hedgehog Signaling Pathway WP4249	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	EVC2
Integrated Cancer Pathway WP1971	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	CDKN1B
Prostaglandin Synthesis and Regulation WP98	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	PTGDS
LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258	2/94	0.6850442087819228	1.0	0	0	0.8510638297872339	0.3219335356890655	DVL3;NLK
Selenium Metabolism and Selenoproteins WP28	1/46	0.688372038071095	1.0	0	0	0.8695652173913043	0.32471811668930733	SELENBP1
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	CDH1
NO/cGMP/PKG mediated Neuroprotection WP4008	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	GRIN2D
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	FES
Human Complement System WP2806	2/97	0.7015629289067601	1.0	0	0	0.8247422680412371	0.29232550701224613	SERPING1;CD59
Differentiation Pathway WP2848	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	KIT
IL-3 Signaling Pathway WP286	1/49	0.7112169323217401	1.0	0	0	0.8163265306122448	0.27818594854238055	PIK3R2
Mesodermal Commitment Pathway WP2857	3/147	0.714987466611623	1.0	0	0	0.8163265306122448	0.2738696046173723	EOMES;HTT;NLK
Photodynamic therapy-induced AP-1 survival signaling. WP3611	1/50	0.7184542048692922	1.0	0	0	0.7999999999999999	0.26452265010260456	BMF
Copper homeostasis WP3286	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	FOXO3
One carbon metabolism and related pathways WP3940	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	GPX7
Electron Transport Chain (OXPHOS system in mitochondria) WP111	2/103	0.7324409619068384	1.0	0	0	0.7766990291262135	0.24184274906292497	COX7A1;SLC25A6
Cardiac Progenitor Differentiation WP2406	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	KIT
Senescence and Autophagy in Cancer WP615	2/105	0.7421134845024052	1.0	0	0	0.761904761904762	0.22724045976090407	CDKN1B;GABARAP
Cardiac Hypertrophic Response WP2795	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	GUCA1A
Hematopoietic Stem Cell Differentiation WP2849	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	HES6
Pathogenic Escherichia coli infection WP2272	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	CDH1
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway WP2018	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	PIK3R2
Complement and Coagulation Cascades WP558	1/58	0.770201320910123	1.0	0	0	0.689655172413793	0.18007127074521875	SERPING1
Preimplantation Embryo WP3527	1/58	0.770201320910123	1.0	0	0	0.689655172413793	0.18007127074521875	CDH1
RIG-I-like Receptor Signaling WP3865	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	DDX3Y
ESC Pluripotency Pathways WP3931	2/116	0.7901054823546598	1.0	0	0	0.689655172413793	0.16247504859752454	DVL3;PIK3R2
Ciliary landscape WP4352	4/216	0.7918338608129156	1.0	0	0	0.7407407407407407	0.17289161546202664	PGRMC2;CBS;DVL3;DCAF11
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863	1/62	0.7923971144117075	1.0	0	0	0.6451612903225806	0.15012426177080712	CD4
G1 to S cell cycle control WP45	1/64	0.8026791537609369	1.0	0	0	0.625	0.13737512770713134	CDKN1B
Hippo-Merlin Signaling Dysregulation WP4541	2/120	0.8055060782966527	1.0	0	0	0.6666666666666666	0.1441896869343059	CDH1;KIT
Histone Modifications WP2369	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	NSD1
DNA Damage Response WP707	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	CDKN1B
Sterol Regulatory Element-Binding Proteins (SREBP) signalling WP1982	1/69	0.8262150460248844	1.0	0	0	0.5797101449275363	0.11066677859030163	FDFT1
miRNA Regulation of DNA Damage Response WP1530	1/71	0.8348251375727604	1.0	0	0	0.5633802816901409	0.10170872796755898	CDKN1B
Peptide GPCRs WP24	1/74	0.8469485510129866	1.0	0	0	0.5405405405405406	0.08979206961117422	ATP8A1
Leptin signaling pathway WP2034	1/76	0.8545332771182171	1.0	0	0	0.5263157894736842	0.08273675463408255	PIK3R2
Regulation of toll-like receptor signaling pathway WP1449	2/139	0.865708767874858	1.0	0	0	0.5755395683453237	0.08299667495615301	PIK3R2;IRAK3
Alzheimers Disease WP2059	1/83	0.8782447070953916	1.0	0	0	0.4819277108433735	0.06256868168843485	GRIN2D
Viral Acute Myocarditis WP4298	1/84	0.8813012287674056	1.0	0	0	0.47619047619047616	0.060169426005052117	CD4
Pyrimidine metabolism WP4022	1/85	0.8842811683327172	1.0	0	0	0.47058823529411764	0.057873036795879476	TK2
Regulation of Actin Cytoskeleton WP51	2/150	0.8922322023032613	1.0	0	0	0.5333333333333333	0.060815394024057466	PIK3R2;SOS2
Allograft Rejection WP2328	1/89	0.8954726961455193	1.0	0	0	0.449438202247191	0.04961957214050512	HLA-G
Cytoplasmic Ribosomal Proteins WP477	1/89	0.8954726961455193	1.0	0	0	0.449438202247191	0.04961957214050512	RPS6KA2
Pancreatic adenocarcinoma pathway WP4263	1/89	0.8954726961455193	1.0	0	0	0.449438202247191	0.04961957214050512	PIK3R2
GPCRs, Other WP117	1/91	0.9006565431609593	1.0	0	0	0.43956043956043955	0.045991775475609106	CELSR2
Corticotropin-releasing hormone signaling pathway WP2355	1/93	0.9055837893531324	1.0	0	0	0.43010752688172044	0.04265611705062928	POMC
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706	2/158	0.9083747840935019	1.0	0	0	0.5063291139240506	0.04865733049604537	VAMP2;HES5
Integrin-mediated Cell Adhesion WP185	1/101	0.9229711233572102	1.0	0	0	0.396039603960396	0.03174547746753108	PIK3R2
Genes related to primary cilium development (based on CRISPR) WP4536	1/103	0.9267934783334831	1.0	0	0	0.38834951456310673	0.029524086681869306	EVC2
Toll-like Receptor Signaling Pathway WP75	1/103	0.9267934783334831	1.0	0	0	0.38834951456310673	0.029524086681869306	PIK3R2
Cell Cycle WP179	1/120	0.952512604294039	1.0	0	0	0.3333333333333333	0.016217313071400133	CDKN1B
GPCRs, Class A Rhodopsin-like WP455	3/257	0.9572910379710701	1.0	0	0	0.4669260700389105	0.020380304521611128	P2RY12;CYSLTR2;OR7C1
mRNA Processing WP411	1/126	0.9592434365308234	1.0	0	0	0.31746031746031744	0.013209648308280598	RBM5
Circadian rhythm related genes WP3594	2/201	0.9627105634283515	1.0	0	0	0.3980099502487562	0.015125361014115263	HEBP1;PTGDS
